129 related articles for article (PubMed ID: 35029032)
1. SRT1720 induces SIRT1-independent cell death in adult T-cell leukemia/lymphoma.
Kozako T; Kato N; Ohsugi T; Uchida YI; Yoshimitsu M; Ishitsuka K; Higaki Y; Sato H; Aikawa A; Honda SI
FEBS J; 2022 Jun; 289(12):3477-3488. PubMed ID: 35029032
[TBL] [Abstract][Full Text] [Related]
2. High expression of the longevity gene product SIRT1 and apoptosis induction by sirtinol in adult T-cell leukemia cells.
Kozako T; Aikawa A; Shoji T; Fujimoto T; Yoshimitsu M; Shirasawa S; Tanaka H; Honda S; Shimeno H; Arima N; Soeda S
Int J Cancer; 2012 Nov; 131(9):2044-55. PubMed ID: 22322739
[TBL] [Abstract][Full Text] [Related]
3. Novel small-molecule SIRT1 inhibitors induce cell death in adult T-cell leukaemia cells.
Kozako T; Suzuki T; Yoshimitsu M; Uchida Y; Kuroki A; Aikawa A; Honda S; Arima N; Soeda S
Sci Rep; 2015 Jun; 5():11345. PubMed ID: 26091232
[TBL] [Abstract][Full Text] [Related]
4. CDK9 Inhibitor Induces Apoptosis, Autophagy, and Suppression of Tumor Growth in Adult T-Cell Leukemia/Lymphoma.
Kato N; Kozako T; Ohsugi T; Uchida Y; Yoshimitsu M; Ishitsuka K; Aikawa A; Honda SI
Biol Pharm Bull; 2023; 46(9):1269-1276. PubMed ID: 37661406
[TBL] [Abstract][Full Text] [Related]
5. SRT1720 induces lysosomal-dependent cell death of breast cancer cells.
Lahusen TJ; Deng CX
Mol Cancer Ther; 2015 Jan; 14(1):183-92. PubMed ID: 25411356
[TBL] [Abstract][Full Text] [Related]
6. High expression of NAMPT in adult T-cell leukemia/lymphoma and anti-tumor activity of a NAMPT inhibitor.
Kozako T; Aikawa A; Ohsugi T; Uchida YI; Kato N; Sato K; Ishitsuka K; Yoshimitsu M; Honda SI
Eur J Pharmacol; 2019 Dec; 865():172738. PubMed ID: 31614144
[TBL] [Abstract][Full Text] [Related]
7. Cell death induced by dorsomorphin in adult T-cell leukemia/lymphoma is AMPK-independent.
Aikawa A; Kozako T; Uchida Y; Yoshimitsu M; Ishitsuka K; Ohsugi T; Honda SI
FEBS J; 2020 Sep; 287(18):4005-4015. PubMed ID: 32027454
[TBL] [Abstract][Full Text] [Related]
8. SRT1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in mice.
Suzuki K; Hayashi R; Ichikawa T; Imanishi S; Yamada T; Inomata M; Miwa T; Matsui S; Usui I; Urakaze M; Matsuya Y; Ogawa H; Sakurai H; Saiki I; Tobe K
Oncol Rep; 2012 Jun; 27(6):1726-32. PubMed ID: 22470132
[TBL] [Abstract][Full Text] [Related]
9. The Sirt1 activator, SRT1720, attenuates renal fibrosis by inhibiting CTGF and oxidative stress.
Ren Y; Du C; Shi Y; Wei J; Wu H; Cui H
Int J Mol Med; 2017 May; 39(5):1317-1324. PubMed ID: 28339034
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor activity of 5-aminoimidazole-4-carboxamide riboside with AMPK-independent cell death in human adult T-cell leukemia/lymphoma.
Aikawa A; Kozako T; Kato N; Ohsugi T; Honda SI
Eur J Pharmacol; 2023 Dec; 961():176180. PubMed ID: 37956732
[TBL] [Abstract][Full Text] [Related]
11. Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin-induced mouse model of asthma.
Ichikawa T; Hayashi R; Suzuki K; Imanishi S; Kambara K; Okazawa S; Inomata M; Yamada T; Yamazaki Y; Koshimizu Y; Miwa T; Matsui S; Usui I; Urakaze M; Matsuya Y; Sasahara M; Tobe K
Respirology; 2013 Feb; 18(2):332-9. PubMed ID: 23062010
[TBL] [Abstract][Full Text] [Related]
12. Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell lines.
Kozako T; Mellini P; Ohsugi T; Aikawa A; Uchida YI; Honda SI; Suzuki T
BMC Cancer; 2018 Aug; 18(1):791. PubMed ID: 30081901
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells.
Chauhan D; Bandi M; Singh AV; Ray A; Raje N; Richardson P; Anderson KC
Br J Haematol; 2011 Dec; 155(5):588-98. PubMed ID: 21950728
[TBL] [Abstract][Full Text] [Related]
14. Neurological and histological consequences induced by in vivo cerebral oxidative stress: evidence for beneficial effects of SRT1720, a sirtuin 1 activator, and sirtuin 1-mediated neuroprotective effects of poly(ADP-ribose) polymerase inhibition.
Gueguen C; Palmier B; Plotkine M; Marchand-Leroux C; Besson VC
PLoS One; 2014; 9(2):e87367. PubMed ID: 24586272
[TBL] [Abstract][Full Text] [Related]
15. Specific Sirt1 Activator-mediated Improvement in Glucose Homeostasis Requires Sirt1-Independent Activation of AMPK.
Park SJ; Ahmad F; Um JH; Brown AL; Xu X; Kang H; Ke H; Feng X; Ryall J; Philp A; Schenk S; Kim MK; Sartorelli V; Chung JH
EBioMedicine; 2017 Apr; 18():128-138. PubMed ID: 28396013
[TBL] [Abstract][Full Text] [Related]
16. Sirtuin 1 alleviates endoplasmic reticulum stress-mediated apoptosis of intestinal epithelial cells in ulcerative colitis.
Ren MT; Gu ML; Zhou XX; Yu MS; Pan HH; Ji F; Ding CY
World J Gastroenterol; 2019 Oct; 25(38):5800-5813. PubMed ID: 31636473
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of SRT1720 on the apoptosis of rabbit chondrocytes by activating SIRT1 via p53/bax and NF-κB/PGC-1α pathways.
Liu B; Lei M; Hu T; Yu F; Xiao DM; Kang H
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):350-355. PubMed ID: 27376802
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 activation by SRT1720 attenuates bone cancer pain via preventing Drp1-mediated mitochondrial fission.
Li MY; Ding JQ; Tang Q; Hao MM; Wang BH; Wu J; Yu LZ; Jiao M; Luo BH; Xie M; Zhu HL
Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):587-598. PubMed ID: 30579931
[TBL] [Abstract][Full Text] [Related]
19. The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction, excessive superoxide production, and inflammation with aging in mice.
Gano LB; Donato AJ; Pasha HM; Hearon CM; Sindler AL; Seals DR
Am J Physiol Heart Circ Physiol; 2014 Dec; 307(12):H1754-63. PubMed ID: 25326534
[TBL] [Abstract][Full Text] [Related]
20. [New treatment strategy for adult T-cell leukemia targeting for anti-tumor immunity and a longevity gene-encoded protein].
Kozako T
Yakugaku Zasshi; 2011; 131(7):1061-72. PubMed ID: 21720136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
